Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 10 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 10813913

    Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted

  2. US 10799580

    Expression vector delivery system and use thereof for inducing an immune response

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  3. US 10786554

    Factor VIII polypeptide formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 29, 2020 · Expires Sep 24, 2040

    granted

  4. US 10781251

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

    Julius-Maximilians-Universitat Wurzburg · Granted Sep 22, 2020 · Expires Sep 17, 2040

    granted

  5. US 10772942

    Lyophilized factor IX formulations

    BIOVERATIV THERAPEUTICS INC. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  6. US 10772906

    Modulation of Factor 11 expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 15, 2020 · Expires Sep 10, 2040

    granted

  7. US 10745680

    Factor IX fusion proteins and methods of making and using same

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 18, 2020 · Expires Aug 13, 2040

    granted

  8. US 10736875

    Methods and compositions associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  9. US 10709799

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  10. US 10703797

    Gene therapy vectors for treatment of Danon disease

    Rocket Pharmaceuticals, Ltd. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  11. US 10696945

    Methods for treating a brain tissue damage by cultured adult pluripotent olfactory stem cells

    China Medical University · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  12. US 10682416

    Epicardial-derived paracrine factors for repairing cardiac tissue

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  13. US 10682393

    Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

    United States Department of Veteran Affairs · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  14. US 10676537

    Antibody targeted to tissue factor, preparation method therefor, and use thereof

    SHANGHAI MIRACOGEN INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  15. US 10668129

    Synergistic combination of neuronal viability factors and uses thereof

    The Regents of the University of California · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  16. US 10668049

    Methods of treating cognitive decline with transforming growth factor beta inhibitors

    The Regents of the University of California · Granted Jun 2, 2020 · Expires May 28, 2040

    granted

  17. US 10662440

    Self-limiting viral vectors encoding nucleases

    Precision BioSciences, Inc. · Granted May 26, 2020 · Expires May 21, 2040

    granted

  18. US 10662183

    Inhibitors of myocardin-related transcription factor and serum response factor (MRTF/SRF)-mediated gene transcription and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 26, 2020 · Expires May 21, 2040

    granted

  19. US 10660918

    Method for enhancing insulin like growth factor 1 receptor expression of mesenchymal stem cell, method for isolating mesenchymal stem cell, and use of mesenchymal stem cell

    China Medical University · Granted May 26, 2020 · Expires May 21, 2040

    granted

  20. US 10646588

    RP2 and RPGR vectors for treating X-linked retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 12, 2020 · Expires May 7, 2040

    granted

  21. US 10619153

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Apr 14, 2020 · Expires Apr 9, 2040

    granted

  22. US 10604565

    Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

    Julius-Maximilians-Universitat Wurzburg · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  23. US 10604548

    Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

    The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

  24. US 10603275

    Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Mar 31, 2020 · Expires Mar 26, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.